Nuveen, LLC Castle Biosciences Inc Transaction History
Nuveen, LLC
- $348 Billion
- Q2 2025
A detailed history of Nuveen, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Nuveen, LLC holds 1,073,107 shares of CSTL stock, worth $24.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,073,107
Previous 671,811
59.73%
Holding current value
$24.7 Million
Previous $13.4 Million
62.93%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
170Shares Held
27.3MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$70.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$49.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$41.4 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$34.3 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$31.7 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $605M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...